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Abstract: Alpha-chloralose (AC) is used to capture nuisance waterfowl so that they can be 
relocated. Concerns for food safety limit its use prior to or during the waterfowl hunting season. 
To determine its half-life in tissue, we administered AC to adult male (n = 7) and female (n = 
5) mallard ducks (Anas platyrhynchos) via oral gavage. A gel capsule containing 100 µCi of 
radioactive AC (14C-AC) and sufficient nonlabeled AC to produce a dose of approximately 30 
mg/kg was given to each duck.The ducks were euthanized at 2, 6, 10, and 18 hours post-
dosing (n = 3 per exposure period), and tissue samples were collected for radioactive analysis. 
Residues observed in edible tissues from ducks dosed with radioactive AC demonstrated a 
delayed uptake as the duck was under the anesthetic effects of the AC. Following the period 
when the ducks were unconscious, most of the AC was rapidly excreted from the body with 
mean half-life (t½) values of 9.0 hours, 9.8 hours, and 9.1 hours for breast muscle, liver, and 
skin, respectively. An approximation of total excretion (99%) was made by taking 7 times the 
t½, resulting in values of between 27 to 33 hours post-exposure. These results suggest that 
tissues from mallard ducks are safe for human consumption 48 hours after dosing, a period 
that is significantly shorter than the FDA-required 30-day withdrawal period.
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Removal or relocation of nuisance wildlife 
is a continuing problem that is being addressed 
by the U.S. Department of Agriculture’s (USDA) 
Animal and Plant Health Inspection Services 
Wildlife Services (WS). Humane removal or 
relocation of nuisance birds, such as Canada 
geese (Branta canadensis) and various species of 
ducks, continues to be a primary goal of WS. 
One tool available for the removal of these 
birds is an immobilizing drug known as alpha-
chloralose (AC; Borg 1955, Belant et al. 1999). 
The drug is a chlorinated acetal derivative of 
glucose prepared by condensing chloral with 
pentose or hexose sugars in the presence of 
sulfuric acid. It has been in use as a human and 
veterinary anesthetic since the 1890s (Hanriot 
and Richet 1893). Although the specific mode 
of action of AC is not fully understood, it is 
assumed to cause depression of the cortical 
centers of the brain (Williams 1966, Lees 1972, 
Silverman and Muir 1993), but at low doses it 
also produces some hyperexcitability (Balis and 
Monroe 1964).
In 1992, the U.S. Food and Drug 
Administration (FDA) granted WS permission 
to use AC under an Investigational New 
Animal Drug application to capture waterfowl 
(Anatidae spp.), pigeons (Columba livia), and 
American coots (Fulica americana). Sandhill 
cranes (Grus canadensis) and common ravens 
(Corvus corax) were allowed by the FDA at a 
later date (Woronecki et al. 1992, O’Hare et al. 
2007).
Widely used by the WS program to control 
pest populations of geese, such as Canada 
geese due to the absence of relevant excretion 
data, AC use is limited by a default moratorium 
for use 30 days before and during waterfowl 
hunting season. Birds captured within 30 days 
of or during open hunting season must either 
be euthanized or held in captivity for 30 days 
prior to release. An absorption, distribution, 
metabolism, and excretion (ADME) study 
conducted with radio-labeled AC is critical for 
generating data to determine a science-based 
use restriction period that protects food safety. 
If all AC derived residues are excreted prior to 
30 days post dosing, it is likely that these data 
can be used to justify a reduction in the length 
of the pre-hunting season moratorium on AC 
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use. Also, if AC residues never reach significant 
concentrations in edible tissues, it may be 
possible eliminate the moratorium.
The objective of this study was to administer 
AC to mallard ducks (Anas platyrhynchos) and 
euthanize them at selected times post-dose 
and analyze edible tissues (breast muscle, 
liver, and skin) to determine residue levels. 
The data would be used to generate a half-life 
of elimination and to evaluate potential risk to 
humans from consumption of these tissues.
Methods
Test material
The test material for this study was AC 
obtained from TCI Chemicals (CAS# 15879-93-
3; Lot# AT01; Tokyo, Japan). The material was 
a mix of the alpha and beta isomers and had 
a certified purity of 89.7%. The radiolabeled 
AC contained only the alpha-isomer and 
was ubiquitously labeled on the glucose ring 
([glucosyl-14C(U)]-alpha-chloralose; 283 mCi/
mmol; 99% radiochemical purity; Perkin Elmer, 
Waltham, Mass.). The beta isomer of chloralose 
does not have significant narcotic activity and 
does not contribute to the dose delivered to 
each duck.
 
Test organism
AC was administered to adult male (n = 7) and 
female ( n = 5) mallard ducks via oral gavage. 
The ducks were obtained from a commercial 
supplier and held in quarantine for 2 weeks 
prior to the start of the study. Each duck was 
weighed prior to receiving a dose of AC to 
ensure delivery of the correct dose. Average 
mass (±SD) of test animals was 1.2 ± 0.13 kg.
 
Test conditions
A gel capsule containing 100 µCi of 14C-AC 
and sufficient nonlabeled AC to produce a 
nominal dose of 30 mg/kg body mass was given 
to each duck before placing it in a stainless 
steel metabolism cage. The stainless steel cage 
was placed inside a Plexiglas™ chamber and 
sealed shut. Air was delivered to the chamber 
by placing a vacuum pump on the exit tube 
from the chamber. Birds had free access to 
food and water for the duration of the test. All 
procedures involving animals were carried 
out with the approval of the National Wildlife 
Research Center (NWRC) Animal Care and Use 
Committee (Protocol QA-1465).
 
Sample collection
The time course was selected based on 
previous experiments that demonstrated that 
greater than 95% of AC in the feces of exposed 
ducks was excreted within 24 hours post dose 
(D. A. Goldade, National Wildlife Research 
Center Study Protocol QA-1060, unpublished 
report). For each time period (2, 6, 10, and 18 
hours), 14C-AC was administered to 3 ducks 
of mixed genders, as described in the section 
above, as a single dose. At the conclusion of 
each exposure time, the ducks were removed 
from their cages and euthanized via exposure 
to CO2. Samples of breast muscle, liver and skin 
were removed from each duck. Tissue samples 
were cut into pieces <3-cm-long and placed in 
a -80° C ± 5° C freezer until frozen completely 
(typically for 2 to 3 hours). Each tissue sample 
was removed from the freezer and placed in 
a cold stainless steel Warring blender with 
between 1 and 2 times its weight of dry ice. 
The sample was blended to a powder and 
transferred to a Nalgene™ bottle of sufficient 
size to contain the entire sample.
 
Liquid scintillation counting analysis
Samples of breast muscle, liver, and skin 
were analyzed for extractable and total 
radioactive content. For the extractable fraction 
analysis, breast muscle, liver, and skin samples 
were removed from the freezer and weighed 
immediately to preserve them in a frozen state. 
A 1.0 g aliquot was weighed into a 10-mL screw 
cap glass test tube. Samples were extracted 
sequentially with acetonitrile (ACN), 0.1N 
hydrochloric acid (HCl), and 6N HCl.
Aliquots of the ACN, 0.1N HCl, and 6N 
HCl extracts were taken and placed into 
individual 20-mL plastic scintillation vials. 
Scintillation cocktail (20 mL of Scintiverse 
BD, Fisher Chemicals, Fair Lawn, N.J.) was 
added to all extracts, and radioactivity was 
determined using a Packard Tri-Carb 1600TR 
liquid scintillation counter (LSC; 4-156 kEV; 
10-minute count time).
 
Total radioactive analysis
A slurry of each sample of tissue was 
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prepared by adding deionized water. The 
sample slurry was mixed, and an aliquot was 
weighed and combusted in an R. J. Harvey 
Model OX-600 Biological Oxidizer. 
Oxygen and nitrogen flows were 350 
mL per minute. The combustion and 
catalyst zone temperatures were held at 
900° C and 680° C, respectively; samples 
were combusted for 4 minutes. The CO2 
produced was trapped in a 14C cocktail 
(R. J. Harvey, Tappan, N.Y.). The cocktail 
was transferred to a glass vial and counted 
on the LSC. Samples were counted 
according to the conditions listed above. 
Statistical analysis
The Method Limit of Detection 
(MLOD) for each tissue was determined 
by following the general procedures 
provided by the Environmental Protection 
Agency (2011). The data were evaluated 
on the basis of concentration of AC 
and metabolites in parts per million of 
AC equivalents (Table 1; Figure 1). AC 
equivalents are defined as unmetabolized 
AC and all metabolites of AC containing 
14C. The results were log-transformed and 
subjected to a linear regression analysis. 
Results of this transformation were used 
to calculate elimination constants (KEl) and 
terminal half-life of elimination (t½) values for 
each tissue between 6 and 18 hours post-dose. 
Figure 1. Elimination of radio-labeled alpha-chloralose (AC) and metabolites from mallard ducks (Anas plat-
yrhynchos) following a single oral dose (n = 3/time point). Values plotted are means ±1 standard deviation.
Table 1. Mean and standard deviations (n = 3) for 
total and extractable alpha-chloralose residue levels 
(mg/kg) in tissues of mallard ducks.  N.D = not 
detectable.
Tissue Time (hours)
Total Extractable
 SD  SD
Breast 2 14.4 1.3 13.6 1.4
6 19.7 1.2 17.6 1.1
10 9.7 1.6 8.3 1.9
18 1.4 0.83 N.D.
Liver 2 24.0 3.2 20.9 1.9
6 32.2 1.3 24.1 0.69
10 21.8 1.3 15.2 2.2
18 5.2 3.7 N.D.
Skin 2 6.9 2.3 6.2 2.0
6 4.4 1.8 6.2 1.5
10 3.3 0.78 3.5 0.71
18 0.38 0.22 N.D.
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The slope of this line yielded the KEl. From this 
value, the terminal half-life of elimination was 
determined. Because a half-life is commonly 
defined as the amount of time it takes for 
one-half of the remaining radioactivity to be 
excreted from the body, 100% elimination can 
never be mathematically achieved. A close 
approximation can be found using 7 times the 
value of t½. This accounts for elimination of 
approximately 99% of the radioactivity.
Mean values from triplicate analyses were 
subjected to 2 analyses of variance. A mixed 
model (PROC MIXED; SAS, Cary, N.C.) was 
used to compare residues among the chemical 
extracts.  Extract (ACN, HCl, reflux), matrix 
(breast, feces, liver, and skin), time (2, 6, 10, and 
18 hours), all 2-way interactions, and the 3-way 
interaction were fixed effects. Subject was a 
random effect.
To compare AC residue data generated by 
extraction and combustion, values determined 
from all 3 extracts (ACN, HCl, reflux) were first 
summed for each sample to yield a total extract 
residue concentration. For analysis using a 
mixed model, a difference response was then 
calculated by subtracting the total extract AC 
residue concentration from the combustion 
value. Matrix (breast, feces, liver, and skin), 
time (2, 6, 10, and 18 hours), and the interaction 
were fixed effects. Subject was a random effect. 
 
Exposure estimation
To estimate the magnitude of potential AC 
exposure from the consumption of tissues 
from AC-treated fowl, the maximum observed 
concentrations of total AC derived residues in 
breast tissue, liver, and skin were multiplied 
by the upper 99th percentile estimate of acute 
chicken meat, liver, and skin consumption, 
respectively. Human chicken consumption 
statistics were obtained from the USDA National 
Health and Nutrition Examination Survey 
(NHANES 2001 to 2006) using SUDAAN Proc 
DESCRIPT. To determine the potential for any 
adverse effects associated with consumption of 
AC residues in poultry, the estimated exposures 
were compared to the estimated acute human 
oral no observed effect level (NOEL) of 0.13 
mg AC/kg body weight. Human NOEL was 
estimated by applying uncertainty factors 
Figure 2. Logarithmic plot of elimination of radiolabeled alpha-chloralose (AC) and metabolites from mal-
lard ducks (Anas platyrhynchos) following a single oral dose (n = 3/time point). Regression lines indicate 
the rate of elimination ±1 standard deviation.
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of ten for interspecies extrapolation and ten 
for conversion of lowest observed effect level 
(LOEL) to NOEL to the LOEL for chickens 
(13.88 mg/kg bodyweight; Loibl et al. 1988).
Results
The MLOD values determined were between 
0.06 and 0.47 µg/g, depending on the tissue. 
The elimination of radioactivity from the edible 
tissues (breast, liver, and skin) all followed a 
similar pattern. Following ingestion of the dose, 
the birds became lethargic as their respiration 
slowed, and they were rendered unconscious 
by the AC. As such, their digestion also slowed 
and the time to maximum AC concentration 
was delayed. The actual maximal value likely 
occurred between 2 and 6 hours post-dose, 
as most of the ducks had returned to an alert 
state 2 or 3 hours post-dose. Therefore, the 
half-life of elimination for AC in these tissues 
was calculated using the 6-, 10- and 18-hour 
observations only. The results reflect this 
treatment of the data and take into account 
the delay in uptake of the AC (Table 2). For 
any future studies, a time point between 2 
and 6 hours might be used to elucidate the 
true maximum residue value. The elimination 
values for each tissue, as well as the P value 
for the slope of the regression lines are given 
(Figure 2; Table 2).
The presence of strongly bound residues in 
exposed tissues could indicate the presence 
of highly reactive metabolites. To assess 
any potential tissue-binding of AC, the data 
generated from solvent extraction of the tissues 
(with ACN, 0.1 N HCl, and 6 N HCl) were 
compared to the results from combustion 
of the same tissues. An ANOVA procedure 
was used to evaluate the difference between 
bound and extractable AC residues at each 
time point. Residue values determined by 
the 2 methods differed by matrix (P < 0.0001), 
but was influenced strongly by time (matrix  
time; P = 0.0002).The main effect of time was 
not significant (P = 0.09). In breast tissue, the 
combustion value was significantly greater than 
the extraction value only at time 6 (P = 0.01). 
In liver, the combustion values were greater 
at all times (P < 0.0001). In skin, the extraction 
value was greater only at time 6 (P = 0.04). In 
all cases, by 16 hours post-dose the extractable 
content had decreased below MLOD levels 
and was only detectable via the more sensitive 
combustion analysis technique (Table 1).
All fixed effects were significant (P < 0.0001) 
except for time (P = 0.05) and time  extract 
(P = 0.07). Owing to the significant extract  
matrix  time interaction, the differences in 
extractable residues for the edible tissues also 
demonstrated some interesting characteristics. 
In all 3 tissues, most of the extractable AC was 
found in the ACN extract. Smaller amounts 
were extracted in the subsequent 0.1 N HCl 
extraction. No additional radioactivity was 
found in the 6 N HCl reflux extraction of skin 
samples. There were detectable residue levels 
in reflux samples from breast muscle at the 6- 
and 10-hour time points. Significant residues 
were found in the liver at the 2-, 6-, and 10-hour 
time points in all 3 extracts. These residue levels 
were noticeably more concentrated than in any 
other tissue.
Discussion
The selected dose of AC (30 mg/kg) was 
representative of a dose that might be received 
by a bird in an actual field capture scenario 
(NWRC SOP WRC-284.R1, Preparing alpha-
chloralose treated grain and bread baits for 
field trials involving waterfowl and other birds, 
1992, unpublished data). The published LD50 
for the test species is 54.6 mg/kg (Williams 
1966). No mortalities were observed during the 
experiments. 
Following AC administration, ducks were 
carefully observed. A very rapid loss of motor 
Table 2. Linear regression statistics for log transformed elimination of alpha-chloralose from mal-
lard ducks (Anas platyrhynchos) for exposure time 6 hours to 18 hours.
Tissue R² Slope p S.E. KEl t½ (hours)
95% C.I. of t½(hours)
99% Elimina-
tion (hours)
Breast 0.928 -0.102 0.00003 0.0108 0.235 9.0 8.4–9.9 27
Liver 0.757 -0.0791     0.002 0.0169 0.182 9.8 8.6–14 33
Skin 0.810 -0.0977   0.0009 0.0179 0.225 9.1 8.2–11 28
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control and lethargy was observed in all of the 
test animals. To minimize errors in preparation 
of the dose, the total mCi of radioactive AC 
was held constant for each experiment. The 
radioactive dose was sufficient to produce a 
detectable signal with as little as 1% of the dose 
present in any tissue analyzed.
The estimated upper bounds of AC exposure 
due to consumption of AC-treated fowl breast 
tissue (Table 1) was 0.081 mg AC/kgbw per 
day. The potential additional consumption 
of poultry skin would contribute ≤0.005 mg 
AC/kgbw per day. This combined (meat and 
skin) upper bound exposure is less than the 
estimated human acute oral no-effect level 
for AC. Estimated upper bound AC exposure 
from consumption of liver from AC treated 
fowl was less than the AC exposure associated 
with breast tissue consumption. As one would 
expect human ingestion of AC treated fowl 
to be infrequent, comparison of the upper 
bounds exposure estimate with the estimated 
acute human no-effect level of 0.13 mg AC/kg 
bodyweight suggests that the risk of adverse 
effects due to consumption of AC treated 
fowl approaches zero. Further, this worst 
case assessment assumed that the AC-derived 
residues were intact AC. It is likely that <10% of 
the tissue residues are AC, with the remainder 
being less potent metabolites. This suggests the 
probability of AC associated adverse effects 
from the consumption of AC treated poultry is 
of no public health concern.
The residues observed in edible tissues from 
ducks dosed with radioactive AC demonstrate 
a delayed uptake as the duck is under the 
effects of the AC and exposure from consuming 
treated ducks during this time period would 
be expected to be quite high. Following the 
duck regaining consciousness, most of the 
AC and metabolites are rapidly excreted from 
the body, with nearly 100% being excreted by 
27 to 33 hours after exposure. The magnitude 
of AC-derived residues suggests that the 
risk of adverse effects due to consumption 
of AC treated fowl is negligible at the end of 
the excretion period. These results support 
shortening the 30-day moratorium on use of 
AC to a much shorter duration.
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